Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
Status:
Completed
Trial end date:
2012-04-28
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of SAR 1118 Ophthalmic Solution (5.0%)
compared to placebo in the treatment of Dry Eye. The safety and tolerability of SAR 1118
Ophthalmic Solution (5.0%) compared to placebo in subjects with dry eye when administered BID
for 12 weeks will also be evaluated.